Company Filing History:
Years Active: 2025
Title: Maoqun Tian: Innovator in KRAS G12D Modulating Compounds
Introduction
Maoqun Tian is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific mutations in the KRAS gene.
Latest Patents
Maoqun Tian holds 1 patent related to KRAS G12D modulating compounds. This patent provides compounds and pharmaceutically acceptable salts that are useful as KRAS G12D and/or KRAS G12C inhibitors. The patent also outlines methods for making and using these compounds, either alone or in combination with additional agents, as well as the pharmaceutical compositions derived from them.
Career Highlights
Maoqun Tian is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its innovative therapies. His work at Gilead focuses on advancing treatments that can significantly impact patient outcomes in oncology.
Collaborations
Maoqun collaborates with Chaodi Dai, a fellow researcher, to further explore the potential of KRAS inhibitors in therapeutic applications.
Conclusion
Maoqun Tian's work in developing KRAS G12D modulating compounds represents a significant advancement in cancer treatment research. His contributions continue to pave the way for innovative therapies that may improve the lives of many patients.